COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patientsAlvino Bisecco, Daniela Cargnelutti, Massimo Filippi et al.|Journal of Neurology|2023Cited by 12
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered surveyManuela Altieri, Antonio Gallo, Rocco Capuano et al.|Multiple Sclerosis and Related Disorders|2023Cited by 2